The pharmaceutical industry should take advantage of the provision for post-approval change management protocols in the International Council on Harmonization’s Q12 guideline to facilitate analytical procedure changes, a member of the guideline’s implementation working group told a 4 February USP meeting.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?